A supramolecular five-component cascade is presented that enables light-controlled transport of an in situ modified ligand between three host systems based on the different complexation preferences of cyclodextrin, cucurbituril, and double-stranded DNA. The results point out novel approaches for the control of drug-DNA interactions in DNA-targeting therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c5cc01025j | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!